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Abstract 
Background: Sex hormone‑binding globulin (SHBG) has been proposed as a biomarker of MetS in children and 
adults. We aim to determine the associations of SHBG with components of MetS in children from the Middle‑East 
where the prevalence of MetS are on the rise.
Methods: In this cross‑sectional study, a total of 509 randomly selected school children (226 boys and 283 girls) aged 
12–16 years were recruited. Fasting blood glucose and lipid profile were determined using routine laboratory proce‑
dures. Serum SHBG is measured with Cobas e411 using an electrochemiluminescence immunoassay. The modified 
definition of ATP‑III (NHANES III) was used for the diagnosis of MetS.
Results: Among 509 children, 23.4 % had metabolic syndrome. Boys had a significantly higher waist circumference 
and systolic blood pressure (p < 0.032, 0.024, respectively) than girls, while levels of glucose (p < 0.029), and SHBG 
(p < 0.003) were significantly higher in girls than in boys. In overall population, a significant inverse correlation of 
SHBG level with age, BMI, systolic blood pressure and triglycerides and a significant direct correlation between SHBG 
level and HDL‑c was exhibited. Children with the lowest tertile of serum SHBG had significantly higher prevalence of 
MetS (p < 0.05). ROC curve shows SHBG level as more sensitive marker of MetS in boys (AUC = 0.70, p < 0.001).
Conclusions: Serum SHBG is significantly more sensitive in identifying MetS in boys, not girls, indicating gender 
dimorphism.
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Background
Metabolic syndrome (MetS) is an assembly of several car-
diometabolic risk factors (including central obesity, insu-
lin resistance, dyslipidemia and hypertension) that may 
predispose towards the development of type 2 diabetes 
mellitus (T2DM) and cardiovascular diseases (CVDs) 
[1–4].
In recent years, there has been a great concern about 
the presence of obesity and metabolic syndrome in 
children. A recent systematic review that included 378 
studies published since 2003 and, depending on different 
classifications, showed the median prevalence of MetS in 
children populations as 3.3 % (range 0–19.2 %), in over-
weight children 11.9 % (range 2.8–29.3 %), and in obese 
children 29.2 % (range 10–66 %) [5].
In the past few decades, Saudi Arabia has shown a very 
rapid development at both the economic and social fields. 
This change has brought about a shift of traditional Ara-
bian diet to a more western dietary pattern predisposing 
adults and children to obesity, T2DM, and hypertension 
[6–9]. The latest national data revealed that the rates of 
overweight and obesity among Saudi school children 
have reached 21 and 9.3 %, respectively [10]. Taha et al. 
demonstrated that obese children and adolescents have 
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Sex hormone-binding globulin (SHBG) is a circulating 
glycoprotein involved in the transportation of sex ster-
oids and is mainly synthesized by the liver [12, 13]. An 
association between SHBG levels with MetS have been 
observed in both men and women [14, 15]. Thus there 
are studies showing strong association of low levels of 
SHBG with obesity [16], insulin resistance [17] and MetS 
in men, women [18] and in pre-pubertal children [19]. 
Moreover, lipid profiles, such as low HDL-C and high 
triglycerides (TG) are associated with low SHBG level in 
the adult population [20, 21].
There are numerous studies in children and adolescents 
relating diabetes (types 1 and 2), cardiovascular risk fac-
tors and prevalence of MetS from different parts of the 
Saudi Arabia [9, 11, 22]. While previous researches have 
already been conducted on the role of SHBG and MetS 
even in children, there is limited data available on specific 
age-groups as well as the existence of gender dimorphism 
[23–27]. Thus, the main objective of our present study 
was to investigate the relation of SHBG levels and com-
ponents of MetS and its potential as an early biomarker 
for MetS in Arab boys and girls 12–16 years of age.
Patients and methods
Subjects
The sample population of this cross-sectional study 
included 509 apparently healthy school children (226 
boys and 283 girls), aged 12–16  years. Children with 
chronic diseases, such as type 1 diabetes mellitus (T1DM) 
and asthma, as well as those on medications that might 
influence the metabolic parameters of interest, were 
excluded. Subjects were recruited randomly from differ-
ent Primary Health Care Centers (PHCC) across Riyadh 
as previously described [28]. Each participating subject 
submitted a general questionnaire containing demo-
graphic, past and present medical history, as well as diet 
information from the food frequency questionnaire. No 
expatriates will be included in the conduct of this study. 
All participants provided written informed consent prior 
to inclusion in the study. Approval was obtained from 
the Ethics Committee of the College of Science Research 
Center, King Saud University, Riyadh, Saudi Arabia.
Anthropometric measurements
With parents’ written consent and oral ascent from the 
children, subjects were invited to their respective PHCC 
in a 10-h overnight fasted state. Anthropometric meas-
urements included height (cm), weight (cm), waist (cm) 
and hip (cm) circumferences and were taken and noted 
by trained nurses. Systolic and diastolic blood pressures 
were taken using pediatric cuffs appropriate to the sub-
ject sizes and were taken twice with a 15-min interval. 
The average of both readings was recorded. Body mass 
index (BMI) was calculated as weight (kg) over height in 
squared meters (m2).
Biochemical measurements
Fasting blood samples were collected and transferred 
immediately to a non-heparinized tube for centrifuga-
tion. Collected sera were then transferred into a pre-
labeled plain tube, stored on ice and delivered to the 
Biomarkers Research Program (BRP) laboratory, King 
Saud University, Riyadh, Saudi Arabia, on the same day 
of collection for immediate storage in a −20  °C freezer 
for immediate analyses. The blood samples were analyzed 
for fasting glucose and lipid profile including HDL-cho-
lesterol, using a chemical analyzer (Konelab, Espoo, Fin-
land). Serum SHBG was measured with a Roche Elecsys 
modular analytics Cobas e411 using an electrochemilu-
minescence immunoassay [ECLIA] (Roche Diagnostics, 
GmbH, Mannheim, Germany). The lower detection limit 
of this assay was 0.35 nmol/L and the intra-assay CV is 
2.6–5.6 %.
Definition of metabolic syndrome
The pediatric definition of MetS by de Ferranti et  al., 
which is analogous to the criteria by the Third Report 
of the Adult Treatment Panel (ATPIII, NHANES III), 
was used for this study [29]. MetS was defined as the 
presence of three out of five abnormalities: hypertri-
glyceridemia  ≥1.1  mM; low HDL-cholesterol (HDL-
C)  <1.3  Mm (boys aged 15–19  years,  <1.17  mM); high 
fasting glucose ≥6.1  mM; central obesity  >75th percen-
tile for age and gender; and hypertension >90th percen-
tile for age, gender and height.
Data analyses
Data were  analyzed  using  SPSS (version 16.5 Chi-
cago, IL, USA).  Continuous data were presented as 
mean ±  standard deviation (SD). Categorical data were 
presented as frequencies and percentages (%). All con-
tinuous variables were checked for normality using the 
Kolmogorov–Smirnov test. Independent Student t test 
and Mann–Whitney U test were used for significance 
for Gaussian and Non-Gaussian variables. Triglycerides 
was log-transformed prior to all parametric analyses. 
Bivariate correlations and linear regressions were done to 
determine associations between SHBG and cardiometa-
bolic parameters. Stepwise linear regression was done in 
all groups and by gender to determine significant predic-
tors using SHBG as dependent variable and the cardio-
metabolic parameters assessed as independent variables. 
Area under the curve (AUC) was done to determine sen-
sitivity of SHBG in predicting MetS and its p value was 
adjusted for multiple comparisons (Bonferroni corrected 
p value = 0.005). All tests were twotailed and p values set 
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on thresholds required to achieve a type 1 error of 0.05. p 
value < 0.05 was considered statistically significant.
Results
The anthropometric and biochemical variables of the 
509 individuals are shown in Table  1. Based on ATPIII 
criteria, 23.4  % had MetS. A significant difference in 
control was observed with MetS children having a 
lower age (p  <  0.001), BMI (p  <  0.004), waist circum-
ference (p  <  0.009), systolic and diastolic blood pres-
sure (p  <  0.001, 0.001, respectively), total cholesterol 
(p < 0.001), glucose, HDL-C and TG (p < 0.000 for all) as 
well a significantly lower SHBG level (p  <  0.006). Char-
acteristics of the control group according to sex is pre-
sented in Additional file 1: Table S1.
Boys with MetS, had significantly higher waist cir-
cumference and systolic blood pressure (p  <  0.032, 
0.024, respectively) than girls, while the levels of glu-
cose (p < 0.029) and SHBG (p < 0.003) were significantly 
higher in girls than boys (Table 2).
Table 3 represents the correlation of SHBG with vari-
ous anthropometric and biochemical parameters in all 
subjects as well as in boys and girls. A significant inverse 
correlation of SHBG level with age, BMI, waist circum-
ference, systolic blood pressure and TG (p < 0.01 for all) 
were observed in the overall population, while a signifi-
cant direct correlation between SHBG level and HDL-C 
were also exhibited in overall group. Importantly, the 
gender stratification showed significant correlations of 
SHBG level with more parameters of MetS in boys than 
girls. Thus, in boys, significant inverse correlations of 
SHBG levels were observed with age, BMI, TG, systolic 
blood pressure (p  <  0.01 all), and waist circumference 
(p < 0.05), while in girls correlations of SHBG were exhib-
ited with BMI, systolic blood pressure (p < 0.01), and TG 
(p < 0.05). A significant direct correlation between SHBG 
level and HDL-C was noticed in both boys and girls.
Stepwise linear regression showed that BMI, systolic and 
diastolic blood pressure, age and HDL-cholesterol cumu-
latively predicted 26.6  % (Adjusted R2 0.256; p  <  0.001) 
of the variances perceived in circulating SHBG in all sub-
jects. Splitting by sex revealed that in boys, the significant 
Table 1 Descriptive statistics of clinical and metabolic characteristics of subject studied (control vs. metabolic syndrome)
Data presented as mean ± standard deviation for normal continuous variables
Significant p‑values (< 0.05) were italicized
a Non‑Gaussian distribution
Parameters Control Metabolic syndrome p value
N (boys/girls) 390 (170/220) 119 (56/63)
Age (years) 13.95 ± 1.18 14.39 ± 1.23 0.001
BMI (kg/m2) 21.69 ± 4.65 23.15 ± 4.36 0.004
Waist circumference (cm) 62.07 ± 20.57 23.15 ± 24.13 0.009
Hip circumference (cm) 76.89 ± 26.51 81.99 ± 28.27 0.076
Systolic blood pressure (mmHg) 117.81 ± 12.88 127.84 ± 16.53 0.000
Diastolic blood pressure (mmHg) 69.50 ± 11.34 74.98 ± 13.86 0.000
Total cholesterol (mmol/l) 3.80 ± 0.93 4.13 ± 1.05 0.001
Glucose (mmol/l) 4.95 ± 0.87 5.55 ± 0.98 0.000
HDL‑cholesterol (mmol/l) 0.96 ± 0.22 0.91 ± 0.22 0.000
Triglycerides (mmol/l)a 1.05 ± 0.47 1.52 ± 0.59 0.000
Sex‑hormone binding globulin (nmol/l) 60.47 ± 29.43 51.76 ± 30.03 0.006
Table 2 Clinical and metabolic characteristics of the meta-
bolic syndrome groups (boys vs. girls)
Data presented as mean ± standard deviation for normal continuous variables 
denotes
Significant p‑values (< 0.05) were italicized
a Non‑Gaussian distribution
Parameters Boys Girls p value
N 56 63
Age (years) 14.39 ± 1.30 14.39 ± 1.17 0.986
BMI (kg/m2) 23.93 ± 4.68 22.54 ± 4.03 0.107
Waist circumference (cm) 73.15 ± 27.52 63.52 ± 19.81 0.032
Hip circumference (cm) 85.11 ± 31.04 79.23 ± 25.52 0.268
Systolic blood pressure 
(mmHg)
131.62 ± 17.71 124.57 ± 14.84 0.024
Diastolic blood pressure 
(mmHg)
74.26 ± 14.07 75.59 ± 13.78 0.619
Total cholesterol (mmol/l) 4.24 ± 0.82 4.03 ± 1.22 0.291
Glucose (mmol/l) 5.34 ± 1.06 5.73 ± 0.86 0.029
HDL‑cholesterol (mmol/l) 0.87 ± 0.23 0.94 ± 0.20 0.081
Triglycerides (mmol/l)a 1.54 ± 0.58 1.50 ± 0.61 0.777
Sex‑hormone binding globulin 
(nmol/l)
42.34 ± 23.32 58.15 ± 30.15 0.003
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predictors for SHBG include BMI, systolic blood pressure 
and age (R2 0.31; p < 0.001) while in girls, the significant 
predictors were BMI and blood pressure (systolic and dias-
tolic) (R2 0.19; p < 0.001) (not shown in tables).
Based on tertiles of SHBG levels, a decrease in the 
prevalence of MetS was observed in the overall and MetS 
group (Fig. 1). However, the effect was more pronounced 
and uniform in boys, showing the highest prevalence of 
MetS with the lowest tertile of SHBG levels, than girls. 
The ROC curves (Fig.  2) show that SHBG levels is a 
more sensitive marker of MetS, with significant values 
in overall subjects (AUC  =  0.61, p  <  0.001) and boys 
(AUC =  0.70, p  <  0.001), but not in girls (AUC =  0.55 
p = NS).
Discussion
To our knowledge, this is the first study to report the gen-
der dimorphic sensitivity of serum SHBG in identifying 
Arab children with MetS. The prevalence of MetS in our 
cohort was 23.4 % and differences in boys and girls were 
observed in the associations of cardiometabolic param-
eters to circulating SHBG. A significant inverse correla-
tion of SHBG level with age, BMI, waist circumference, 
systolic blood pressure, and TG, and a positive correla-
tion of HDL-C was observed. SHBG was associated in 
determining full MetS in boys, not girls.
In the year 2010, a cross-sectional observational study, 
based on the same definition to define MetS as the pre-
sent one, including a total of 1231 Saudi children and 
adolescents demonstrated that the prevalence of MetS 
manifestations among Arab children is extremely high 
with overall prevalence of complete MetS as high as 9.4 % 
[22]. Although not a representative of the Saudi chil-
dren population, this study demonstrated an alarmingly 
high prevalence of MetS in the Arab children, as high as 
23.4  %. The main causative factors, such as overweight 
and obesity, which lead to increased prevalence of MetS 
and other non-communicable diseases in both children 
and adults, have been mainly contributed by unhealthy 
dietary patterns, low physical activity and, to some 
extent, the social norms of the society [30–33].
Important hormonal changes takes place during 
puberty age in boys and girls. Pinkney and colleagues 
Table 3 Correlation coefficients of  SHBG with  metabolic 
parameters for all subjects, boys and girls
Data presented as coefficient (R)
* p < 0.05, ** p < 0.01
a Denotes log transformed
Parameters All subjects Boys Girls
N 509 265 244
Age (years) −0.224** −0.311** −0.123
BMI (kg/m2) −0.399** −0.390** −0.399**
Waist circumference (cm) −0.104* −0.128* −0.073
Hip circumference (cm) −0.068 −0.107 −0.027
Systolic blood pressure (mmHg) −0.319** −0.339** −0.284**
Diastolic blood pressure (mmHg) −0.045 −0.087 0.009
Total cholesterol (mmol/l) −0.007 −0.061 0.039
Glucose (mmol/l) −0.076 −0.046 −0.127
HDL‑cholesterol (mmol/l) 0.280** 0.311** 0.236**
Triglycerides (mmol/l)a −0.206** −0.242** −0.166*
Fig. 1 Prevalence of MetS based on tertiles of SHBG level. NS non‑significant
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demonstrated that SHBG level keeps increasing in the 
earlier stage of childhood with a gradual decline as 
they reach their age at puberty, and that this effect is 
predominant in boys [34]. Moreover, in a cross-sec-
tional study performed by Garces and colleagues includ-
ing pubertal children (age: 12–15  years), a significantly 
higher SHBG level was demonstrated in girls than boys, 
reinforcing that the sex and growth hormone variations 
during puberty manifests earlier in girls than boys of 
the same age. In addition, a significant inverse relation 
between testosterone and SHBG level was shown in boys, 
with a gradual increase with age, while this effect was not 
uniform in girls with SHBG levels not showing significant 
differences based on age groups [35]. This study includes 
boys and girls with advancing age and puberty and sup-
ports the above results, showing significantly lower 
SHBG levels in boys than girls in MetS.
The correlation results observed in our study are 
interesting in the way that they are associated with car-
diometabolic risk factors in boys and girls. These results 
demonstrating an inverse correlation between age and 
SHBG level with a significant value in boys supports 
the findings of de Oya et al. [25], Pinkney et al. [34] and 
Sorensen et al. [36].
Insulin down-regulates hepatic SHBG production 
[19], while an inverse correlation between BMI and 
insulin sensitivity has been shown in various studies 
in obese children and adolescents [37, 38]. Our study 
demonstrating an inverse correlation between BMI and 
SHBG levels is also in accordance with previous investi-
gations in children [39, 40]. Krishnasamy and colleagues 
demonstrated an inverse relation between SHBG levels 
and waist circumference, as well as body mass index 
percentile in children at risk for MetS [23]. Our study 
partially supports the above results showing a signifi-
cant inverse correlation between SHBG levels and waist 
circumference but only in boys. There is evidence show-
ing an inverse association between SHBG, BP and TG in 
adults and children [40, 41]. The studies also observed 
a direct association of SHBG with HDL-c level. Our 
study supports the above results showing a significant 
inverse correlation between SHBG, systolic BP and TG 
levels and a direct relation between SHBG with HDL-c 
levels in the MetS group including boys and girls. The 
lowest tertile of SHBG level showed a higher prevalence 
of MetS in boys, with a uniform inverse trend than girls. 
The possible explanation for this trend may the corre-
lation of SHBG level with more MetS components as 
compared to girls. The ROC analysis also supports the 
above trend which shows SHBG as a clearer predictor of 
MetS components in boys than girls.
Conclusions
In conclusion, our study showed that SHBG is a sensitive 
predictor of metabolic syndrome in boys and not girls. 
This study is limited with its cross-sectional study design 
Fig. 2 Receiver operating characteristic (ROC) analysis curve using 
SHBG serum levels as a predictor of MetS
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which prevents causality. The study is nevertheless one of 
the few to demonstrate significant gender dimorphism 
of SHBG’s influence in children of a specific age-group. 
The use of SHBG as a useful marker to identify boys with 
increased cardiometabolic risk is promising.
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